TrialLancet (London, England)2010

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.

Sheena McCormack et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.